Waddell & Reed Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,816	Closed	-$1.9M	–	591
2016 Q3	$1.9M	Hold	29,816	–	–	﹤0.01%	566
2016 Q2	$2.22M	Hold	29,816	–	–	﹤0.01%	557
2016 Q1	$1.99M	Buy	+29,816	New	+$1.99M	﹤0.01%	571